ATE238348T1 - Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen - Google Patents

Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen

Info

Publication number
ATE238348T1
ATE238348T1 AT96939132T AT96939132T ATE238348T1 AT E238348 T1 ATE238348 T1 AT E238348T1 AT 96939132 T AT96939132 T AT 96939132T AT 96939132 T AT96939132 T AT 96939132T AT E238348 T1 ATE238348 T1 AT E238348T1
Authority
AT
Austria
Prior art keywords
compositions containing
medications
peptides derived
thymic hormones
conjugate peptides
Prior art date
Application number
AT96939132T
Other languages
English (en)
Inventor
D Hinterland Lucien Dussourd
Anne-Marie Pinel
Original Assignee
Inst Europeen Biolog Cellulair
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Europeen Biolog Cellulair filed Critical Inst Europeen Biolog Cellulair
Application granted granted Critical
Publication of ATE238348T1 publication Critical patent/ATE238348T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/66Thymopoietins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/062Serum thymic factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
AT96939132T 1995-11-15 1996-11-15 Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen ATE238348T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9513544A FR2741076B1 (fr) 1995-11-15 1995-11-15 Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
PCT/FR1996/001812 WO1997018239A1 (fr) 1995-11-15 1996-11-15 Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant

Publications (1)

Publication Number Publication Date
ATE238348T1 true ATE238348T1 (de) 2003-05-15

Family

ID=9484596

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96939132T ATE238348T1 (de) 1995-11-15 1996-11-15 Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen

Country Status (10)

Country Link
US (1) US6211155B1 (de)
EP (1) EP0861266B3 (de)
JP (1) JP2000500447A (de)
AT (1) ATE238348T1 (de)
AU (1) AU7683296A (de)
CA (1) CA2237995C (de)
DE (2) DE69627691T4 (de)
ES (1) ES2196187T7 (de)
FR (1) FR2741076B1 (de)
WO (1) WO1997018239A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030948A (en) * 1997-12-19 2000-02-29 Mann; Morris A. Hair regeneration compositions for treatment of alopecia and methods of application related thereto
US6462019B1 (en) * 1998-07-10 2002-10-08 Osteoscreen, Inc. Inhibitors of proteasomal activity and production for stimulating bone growth
US6902721B1 (en) 1998-07-10 2005-06-07 Osteoscreen, Inc. Inhibitors of proteasomal activity for stimulating bone growth
US20070015698A1 (en) * 1998-07-30 2007-01-18 United States Of America As Represented By The Secretary Of Health Treatment of skin, and wound repair, with thymosin beta 4
EP1100529B2 (de) * 1998-07-30 2010-08-25 The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health Thymosin beta 4 stimuliert wundheilung
FR2857667B1 (fr) * 2003-07-18 2007-07-13 Inst Europ Biolog Cellulaire Nouveaux conjugues peptidiques utiles dans le traitement preventif et curatif de l'alopecie
FR2857597B1 (fr) 2003-07-18 2008-01-25 Inst Europeen Biolog Cellulair Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
WO2005035549A2 (en) * 2003-10-14 2005-04-21 Kernel Biopharma Inc. Amiphiphylic peptide-pna conjugates for the delivery of pna through the blood brain barrier
ES2355571T3 (es) * 2004-03-26 2011-03-29 Dsm Ip Assets B.V. Conjugados de ácidos arilalquílicos con aminoácidos y péptidos para usos cosméticos.
FR2899105B1 (fr) * 2006-03-30 2012-07-27 Soc Extraction Principes Actif Composition cosmetique et/ou pharmaceutique comprenant comme ingredient actif, au moins un hydrolysat de proteines de poacees et utilisation de cet hydrolysat
CA2701420C (en) * 2007-10-29 2016-02-09 Helix Biomedix Inc. Protective skin care tetrapeptides
AU2008328682A1 (en) * 2007-11-30 2009-06-04 Immundiagnostik Ag Composition for treatment and prevention of hair loss and premature graying of hair
FR3042192B1 (fr) 2015-10-09 2017-12-08 Inst Europeen De Biologie Cellulaire Peptides utiles dans le traitement preventif et curatif de l'alopecie
US20180228837A1 (en) * 2017-02-15 2018-08-16 Tanya Rhodes Stable iodine solutions with medical applications
CU24626B1 (es) 2019-12-26 2022-11-07 Centro Nac De Biopreparados Composición farmacéutica a base de proteínas con actividad neuroprotectora, inmunomoduladora, antiinflamatoria y antimicrobiana

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301065A (en) * 1977-05-25 1981-11-17 Agence Nationale De Valorisation De La Recherche (Anvar) Novel polypeptides having thymic activity or an antagonistic activity and processes for their synthesis
NZ189101A (en) * 1977-12-08 1984-07-06 Ortho Pharma Corp Polypeptides having the ability to induce differentiation of both th-1+ t-lymphocytes and bu-1+ b-lymphocytes;pharmaceutical compositions
JPS5852225A (ja) * 1981-09-22 1983-03-28 Mitsui Pharmaceut Inc 脱髄疾患治療剤
JPS6089499A (ja) * 1983-10-21 1985-05-20 Mitsui Pharmaceut Inc ペプチド
US4629723A (en) * 1984-06-27 1986-12-16 Ortho Pharmaceutical Corporation Potent thymopentin analogs

Also Published As

Publication number Publication date
DE69627691T4 (de) 2009-10-08
AU7683296A (en) 1997-06-05
EP0861266A1 (de) 1998-09-02
EP0861266B1 (de) 2003-04-23
DE69627691T2 (de) 2004-03-11
CA2237995A1 (fr) 1997-05-22
JP2000500447A (ja) 2000-01-18
FR2741076B1 (fr) 1998-01-30
DE69627691D1 (de) 2003-05-28
CA2237995C (fr) 2011-08-09
EP0861266B3 (de) 2009-04-08
WO1997018239A1 (fr) 1997-05-22
ES2196187T7 (es) 2009-11-05
US6211155B1 (en) 2001-04-03
ES2196187T3 (es) 2003-12-16
FR2741076A1 (fr) 1997-05-16

Similar Documents

Publication Publication Date Title
ATE238348T1 (de) Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen
DE69627019D1 (de) PEPTIDKONJUGATE, DEREN VERWENDUNG ALS HEILMITTEL UND ZUSAMMENSeTZUNGen, DIEse ENTHALTENd
DK2016950T3 (da) Farmaceutisk sammensætning omfattende et exendin-4-peptid
EP0696208A4 (de) Orale dareichungsform und verfahren
ATE308998T1 (de) Langwirkende arzneistoffe und diese enthaltende arzneimittel
FI945912A0 (fi) Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö
WO2000012542A3 (en) Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
PL309776A1 (en) Ionic molecule conjugates from biodegradable polyesters and biologically active polypeptides
ATE120374T1 (de) Markierte polypeptidderivate.
DK1188768T3 (da) LHRH-antagonisk-peptider
ATE297219T1 (de) Antikörper als arzneimittel gegen lymphocytische tumore (ausschliesslich myelome)
KR900016259A (ko) 신규한 펩티드, 및 그것을 함유하는 항치매제
EP2046813B1 (de) Proteinbindende methotrexat-derivate und diese enthaltende arzneimittel
FR2768341B1 (fr) Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides
TR199902575T2 (xx) Peptitler, proteinler ve nükleik asitler için stabil farmasötik uygulama formu.
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
ATE216234T1 (de) Zusammensetzungen aus aminosäure zur behandlung von infektionen
KR940021074A (ko) Vip, 또는 그의 유사체, 유도체 또는 단편으로 이루어지는 제약 조성물
RU95105590A (ru) Гепатотропные конъюгаты антивирусных лекарственных средств, их носители, содержащие их фармацевтические композиции, способ получения конъюгатов
KR970058720A (ko) 향균 및 항진균 활성을 갖는 펩타이드
KR970058721A (ko) 향균 및 항진균 활성을 갖는 펩타이드
TH35998A (th) Lh-rh เป็ปไทด์ อะนาล็อก ประโยชน์ของสิ่งเหล่านั้นและองค์ประกอบทางเภสัชกรรมซึ่งประกอบด้วยสิ่งเหล่านั้น
KR840007567A (ko) 펩티드의 제조방법
KR910004663A (ko) 정신-약리학적 펩티드

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties